The sustained activity of the NLRP3-inflammasome signaling pathway in the microglia holds potential for developing adverse effects such as chronic inflammation in the brain, which dampens microglial capacity to degrade misfolded protein deposits such as Aβ aggregates, laying a foundation for the AD pathogenesis [127]. The gene discussed is NLRP3; the disease is Alzheimer disease.